Market Insights Health Hospitals Inpatient Care

Gastroenterology - United States

United States

The Gastroenterology market in the United States is expected to experience significant growth in the coming years.
It is projected that by 2024, the revenue in this market will reach a staggering €56.09bn.
This growth is expected to continue at a steady pace, with an annual growth rate (CAGR 2024-2029) of 1.85%.
As a result, the market volume is estimated to reach €61.48bn by 2029.
When compared globally, United States is set to generate the most revenue in the Gastroenterology market.
In 2024 alone, United States is projected to generate €56.09bn in revenue.
This highlights the significant impact and dominance of the United States in this particular market.
The United States is experiencing a growing demand for advanced endoscopic procedures in the field of gastroenterology.

Key regions: France, China, Japan, United States, Europe

Marché

Région

Comparaison de régions

Monnaie

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.